Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports
The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.

Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Jul 4, 2024 0 231
usnews Jul 4, 2024 0 229
usnews Jul 4, 2024 0 224
usnews Jul 4, 2024 0 223
usnews Jul 4, 2024 0 222